Hypoxia inducible factor-1α inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death

Elena Favaro, Giorgia Nardo, Luca Persano, Massimo Masiero, Lidia Moserle, Rita Zamarchi, Elisabetta Rossi, Giovanni Esposito, Mario Plebani, Ulrike Sattler, Thomas Mann, Wolfgang Mueller-Klieser, Vincenzo Ciminale, Alberto Amadori, Stefano Indraccolo

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Hypoxia and the acquisition of a glycolytic phenotype are intrinsic features of the tumor microenvironment. The hypoxia inducible factor-1α (HIF-1α) pathway is activated under hypoxic conditions and orchestrates a complex transcriptional program that enhances cell survival. Although the consequences of HIF-1α inactivation in cancer cells have been widely investigated, only a few studies have addressed the role of HIF-1α in the survival of cancer cells endowed with different glycolytic capacities. In this study, we investigated this aspect in ovarian cancer cells. Hypoxia-induced toxicity was increased in highly glycolytic cells compared with poorly glycolytic cells; it was also associated with a sharp decrease in intracellular ATP levels and was prevented by glucose supplementation. Stable HIF-1α silencing enhanced hypoxia-induced cell death in vitro due to a lack of cell cycle arrest. Tumors bearing attenuated HIF-1α levels had similar growth rates and vascularization as did controls, but tumors showed higher proliferation levels and increased necrosis. Moreover, tumors formed by HIF-1α deficient cells had higher levels of lactate and lower ATP concentrations than controls as shown by metabolic imaging. The findings that such metabolic properties can affect the survival of cancer cells under hypoxic conditions and that these properties contribute to the determination of the consequences of HIF-1α inactivation could have important implications on the understanding of the effects of anti-angiogenic and HIF-1α-targeting drugs in cancer.

Original languageEnglish
Pages (from-to)1186-1201
Number of pages16
JournalAmerican Journal of Pathology
Volume173
Issue number4
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Hypoxia-Inducible Factor 1
Cell Death
Neoplasms
Cell Survival
Adenosine Triphosphate
Tumor Microenvironment
Tumor Hypoxia
Drug Delivery Systems
Cell Cycle Checkpoints
Ovarian Neoplasms
Lactic Acid
Necrosis
Phenotype
Glucose

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hypoxia inducible factor-1α inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. / Favaro, Elena; Nardo, Giorgia; Persano, Luca; Masiero, Massimo; Moserle, Lidia; Zamarchi, Rita; Rossi, Elisabetta; Esposito, Giovanni; Plebani, Mario; Sattler, Ulrike; Mann, Thomas; Mueller-Klieser, Wolfgang; Ciminale, Vincenzo; Amadori, Alberto; Indraccolo, Stefano.

In: American Journal of Pathology, Vol. 173, No. 4, 10.2008, p. 1186-1201.

Research output: Contribution to journalArticle

Favaro, Elena ; Nardo, Giorgia ; Persano, Luca ; Masiero, Massimo ; Moserle, Lidia ; Zamarchi, Rita ; Rossi, Elisabetta ; Esposito, Giovanni ; Plebani, Mario ; Sattler, Ulrike ; Mann, Thomas ; Mueller-Klieser, Wolfgang ; Ciminale, Vincenzo ; Amadori, Alberto ; Indraccolo, Stefano. / Hypoxia inducible factor-1α inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. In: American Journal of Pathology. 2008 ; Vol. 173, No. 4. pp. 1186-1201.
@article{eca503d0a498405d881800fd79d2308a,
title = "Hypoxia inducible factor-1α inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death",
abstract = "Hypoxia and the acquisition of a glycolytic phenotype are intrinsic features of the tumor microenvironment. The hypoxia inducible factor-1α (HIF-1α) pathway is activated under hypoxic conditions and orchestrates a complex transcriptional program that enhances cell survival. Although the consequences of HIF-1α inactivation in cancer cells have been widely investigated, only a few studies have addressed the role of HIF-1α in the survival of cancer cells endowed with different glycolytic capacities. In this study, we investigated this aspect in ovarian cancer cells. Hypoxia-induced toxicity was increased in highly glycolytic cells compared with poorly glycolytic cells; it was also associated with a sharp decrease in intracellular ATP levels and was prevented by glucose supplementation. Stable HIF-1α silencing enhanced hypoxia-induced cell death in vitro due to a lack of cell cycle arrest. Tumors bearing attenuated HIF-1α levels had similar growth rates and vascularization as did controls, but tumors showed higher proliferation levels and increased necrosis. Moreover, tumors formed by HIF-1α deficient cells had higher levels of lactate and lower ATP concentrations than controls as shown by metabolic imaging. The findings that such metabolic properties can affect the survival of cancer cells under hypoxic conditions and that these properties contribute to the determination of the consequences of HIF-1α inactivation could have important implications on the understanding of the effects of anti-angiogenic and HIF-1α-targeting drugs in cancer.",
author = "Elena Favaro and Giorgia Nardo and Luca Persano and Massimo Masiero and Lidia Moserle and Rita Zamarchi and Elisabetta Rossi and Giovanni Esposito and Mario Plebani and Ulrike Sattler and Thomas Mann and Wolfgang Mueller-Klieser and Vincenzo Ciminale and Alberto Amadori and Stefano Indraccolo",
year = "2008",
month = "10",
doi = "10.2353/ajpath.2008.071183",
language = "English",
volume = "173",
pages = "1186--1201",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Hypoxia inducible factor-1α inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death

AU - Favaro, Elena

AU - Nardo, Giorgia

AU - Persano, Luca

AU - Masiero, Massimo

AU - Moserle, Lidia

AU - Zamarchi, Rita

AU - Rossi, Elisabetta

AU - Esposito, Giovanni

AU - Plebani, Mario

AU - Sattler, Ulrike

AU - Mann, Thomas

AU - Mueller-Klieser, Wolfgang

AU - Ciminale, Vincenzo

AU - Amadori, Alberto

AU - Indraccolo, Stefano

PY - 2008/10

Y1 - 2008/10

N2 - Hypoxia and the acquisition of a glycolytic phenotype are intrinsic features of the tumor microenvironment. The hypoxia inducible factor-1α (HIF-1α) pathway is activated under hypoxic conditions and orchestrates a complex transcriptional program that enhances cell survival. Although the consequences of HIF-1α inactivation in cancer cells have been widely investigated, only a few studies have addressed the role of HIF-1α in the survival of cancer cells endowed with different glycolytic capacities. In this study, we investigated this aspect in ovarian cancer cells. Hypoxia-induced toxicity was increased in highly glycolytic cells compared with poorly glycolytic cells; it was also associated with a sharp decrease in intracellular ATP levels and was prevented by glucose supplementation. Stable HIF-1α silencing enhanced hypoxia-induced cell death in vitro due to a lack of cell cycle arrest. Tumors bearing attenuated HIF-1α levels had similar growth rates and vascularization as did controls, but tumors showed higher proliferation levels and increased necrosis. Moreover, tumors formed by HIF-1α deficient cells had higher levels of lactate and lower ATP concentrations than controls as shown by metabolic imaging. The findings that such metabolic properties can affect the survival of cancer cells under hypoxic conditions and that these properties contribute to the determination of the consequences of HIF-1α inactivation could have important implications on the understanding of the effects of anti-angiogenic and HIF-1α-targeting drugs in cancer.

AB - Hypoxia and the acquisition of a glycolytic phenotype are intrinsic features of the tumor microenvironment. The hypoxia inducible factor-1α (HIF-1α) pathway is activated under hypoxic conditions and orchestrates a complex transcriptional program that enhances cell survival. Although the consequences of HIF-1α inactivation in cancer cells have been widely investigated, only a few studies have addressed the role of HIF-1α in the survival of cancer cells endowed with different glycolytic capacities. In this study, we investigated this aspect in ovarian cancer cells. Hypoxia-induced toxicity was increased in highly glycolytic cells compared with poorly glycolytic cells; it was also associated with a sharp decrease in intracellular ATP levels and was prevented by glucose supplementation. Stable HIF-1α silencing enhanced hypoxia-induced cell death in vitro due to a lack of cell cycle arrest. Tumors bearing attenuated HIF-1α levels had similar growth rates and vascularization as did controls, but tumors showed higher proliferation levels and increased necrosis. Moreover, tumors formed by HIF-1α deficient cells had higher levels of lactate and lower ATP concentrations than controls as shown by metabolic imaging. The findings that such metabolic properties can affect the survival of cancer cells under hypoxic conditions and that these properties contribute to the determination of the consequences of HIF-1α inactivation could have important implications on the understanding of the effects of anti-angiogenic and HIF-1α-targeting drugs in cancer.

UR - http://www.scopus.com/inward/record.url?scp=53149153157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53149153157&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2008.071183

DO - 10.2353/ajpath.2008.071183

M3 - Article

VL - 173

SP - 1186

EP - 1201

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -